RNS Number:7465J
Medical Marketing Int'l Group PLC
08 April 2003


FOR IMMEDIATE RELEASE                                               8 APRIL 2003


                   MEDICAL MARKETING INTERNATIONAL GROUP PLC


Medical Marketing International Group plc ("MMI"), the Cambridge UK-based
technology management company traded on AIM, notes that CellFactors plc has
announced that it has exceeded the minimum subscription of #2.125 million in its
current offer for shares in the company. Prior to this issue, MMI held 26% of
CellFactors' issued ordinary share capital. CellFactors also commented that it
is continuing its fundraising efforts in order to reach a total of #3.5 million
by the final close date of 30 April.


CellFactors is a relatively small part of MMI's business. Currently MMI's active
interests including The Bioscience Innovation Centre, The BioScience VCT, and
Tek-check are all developing well, as are its other biobaby companies, in
particular Oncosense, its wholly-owned cancer therapeutics business.


For further information, please contact:-


David Best, Executive Chairman
MMI Group plc                                                       01223 477677


Lisa Baderoon
Buchanan Communications                                            020 7466 5000




                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

MSCNKOKBOBKDPQK